The allotment for the Corona Remedies Ltd. IPO was finalised on 11 December 2025, marking an important step for investors who applied to the ₹655-crore issue. The IPO, which opened from 8 to 10 December, received an exceptionally strong response across all investor categories, making it one of the most subscribed issues of the year.
Investors can now check whether they have been allotted shares. The allotment status is available on the website of Bigshare Services, the official registrar for the IPO. Applicants can log in using their PAN number, application number, or DP ID. The allotment details can also be checked on the BSE and NSE portals. Those who have received shares will see them credited to their demat accounts by 12 December, while refunds for non-allottees will also be processed on the same day.
The Corona Remedies IPO received a huge market response, with the issue subscribed over 130 to 137 times. This means demand was far greater than the shares available, indicating strong interest from investors ranging from retail buyers to qualified institutional investors (QIIs) and high-net-worth individuals. The high subscription levels show the confidence investors have in the company’s business, growth record, and presence in the pharmaceutical sector.
Grey market activity has also remained strong. The IPO is trading at a premium of around 27–28%, signaling expectations of a positive listing. A strong grey market premium usually reflects positive sentiment and indicates that investors believe the stock may list above the upper end of the price band, which for this IPO was ₹1,008 to ₹1,062 per share.
Corona Remedies is a growing pharmaceutical company with a diverse portfolio across women’s health, cardio-diabetes, pain management, urology, and nutritional supplements. Its steady revenue growth and nationwide distribution network have added to investor confidence.
The stock is scheduled to list on the BSE and NSE on 15 December 2025, and market watchers will be closely observing its debut price and trading movement. For now, investors are checking the allotment details and preparing for the stock’s listing, which is expected to draw strong interest on opening day.
Also Read: TCS to buy US firm Coastal Cloud for $700 million
